Assignee
COVAGEN AG
CH·6 granted patents·4 pending applications·13 citations·filing 2013–2020
Top patents by PatentIndex Score
10 records- 0180US10364419B2Human serum albumin binding compounds and fusion proteins thereofCOVAGEN AG·Filed 2017·Granted Jul 30, 2019·3 cites·10 claims
- 0279US9790475B2Human serum albumin binding compounds and fusion proteins thereofCOVAGEN AG·Filed 2013·Granted Oct 17, 2017·4 cites·8 claims
- 0378US9593314B2Binding molecules with antitumoral activityCOVAGEN AG·Filed 2013·Granted Mar 14, 2017·5 cites·10 claims
- 0458US9315557B2IL-17A binding molecules and medical uses thereofCOVAGEN AG·Filed 2013·Granted Apr 19, 2016·1 cites·18 claims
- 0553US11351267B2FGFR3 binding moleculesCOVAGEN AG·Filed 2020·Granted Jun 7, 2022·0 cites·12 claims
- 0651US10722589B2FGFR3 binding moleculesCOVAGEN AG·Filed 2018·Granted Jul 28, 2020·0 cites·12 claims
- 0742US2017281768A1Novel nucleic acid molecules with antitumoral activityCOVAGEN AG·Filed 2017·Application pending·0 cites
- 0840US2019100587A1IgG1 Fc MUTANTS WITH ABLATED EFFECTOR FUNCTIONSCOVAGEN AG·Filed 2018·Application pending·0 cites
- 0939US2016368957A1IL-17 Binding Compounds and Medical Uses ThereofCOVAGEN AG·Filed 2016·Application pending·0 cites
- 1037US2019153096A1Cd3/cd33 bispecific binding moleculesCOVAGEN AG·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when COVAGEN AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →